Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Azacitidine MeSH Descriptor Data 2025


MeSH Heading
Azacitidine
Tree Number(s)
D02.145.150
D03.383.742.680.245.217
D13.570.685.245.217
D13.570.800.286.300
Unique ID
D001374
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D001374
Scope Note
A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
Entry Term(s)
5-Azacytidine
Azacytidine
NSC-102816
Vidaza
Pharm Action
Antimetabolites, Antineoplastic
Enzyme Inhibitors
Registry Numbers
M801H13NRU
0
Related Numbers
320-67-2
CAS Type 1 Name
1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
Previous Indexing
Nucleosides (1966-1971)
Triazines (1966-1971)
Public MeSH Note
96; was AZACYTIDINE 1974-95
History Note
96; was AZACYTIDINE 1972-95 (Prov 1972-73)
Date Established
1974/01/01
Date of Entry
1999/01/01
Revision Date
2017/05/24
Azacitidine Preferred
NSC-102816 Narrower
Vidaza Narrower
page delivered in 0.148s